FCDGC: MAN2A2 Enzyme Variant Causes New Type of Congenital Disorder of Glycosylation
Dec 5, 2022 ·
1m 56s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). This summary is based on a paper published in the Journal of Medical Genetics on November 10, 2022,...
show more
New research from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). This summary is based on a paper published in the Journal of Medical Genetics on November 10, 2022, titled "Homozygous truncating variant in MAN2A2 causes a novel congenital disorder of glycosylation with neurological involvement."
Read the paper here: https://jmg.bmj.com/content/early/2022/11/10/jmg-2022-108821
Learn more about FCDGC: https://www.rarediseasesnetwork.org/fcdgc
show less
Read the paper here: https://jmg.bmj.com/content/early/2022/11/10/jmg-2022-108821
Learn more about FCDGC: https://www.rarediseasesnetwork.org/fcdgc
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
